Serpin Fusion Polypeptides and Methods of Use Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 61/502,055, filed Jun 28, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,980,266 | Serpin Fusion Polypeptides and Methods of Use Thereof In force · High confidence | Sanofi Aatd Inc. | In force | High confidence | ||
| US 10,400,029 | Serpin Fusion Polypeptides and Methods of Use Thereof In force · High confidence | Sanofi Aatd Inc. | In force | High confidence | ||
| US 10,723,785 | Serpin Fusion Polypeptides and Methods of Use Thereof In force · High confidence | Sanofi Aatd Inc. | In force | High confidence | ||
| US 10,730,929 | Serpin Fusion Polypeptides and Methods of Use Thereof In force · High confidence | Sanofi Aatd Inc. | In force | High confidence | ||
| US 11,046,752 | Serpin Fusion Polypeptides and Methods of Use Thereof In force · High confidence | Sanofi Aatd Inc. | In force | High confidence | ||
| US 11,827,691 | Serpin Fusion Polypeptides and Methods of Use Thereof In force · High confidence | Sanofi Aatd Inc. | In force | High confidence | ||
| US 11,965,017 | Serpin Fusion Polypeptides and Methods of Use Thereof In force · High confidence | Sanofi Aatd Inc. | In force | High confidence | ||
| US 9,920,109 | Serpin Fusion Polypeptides And Methods Of Purification Thereof In force · High confidence | Sanofi Aatd Inc. | In force | High confidence | ||
| Application 16/393,619 | Serpin Fusion Polypeptides and Methods of Use Thereof Abandoned Abandoned Feb 10, 2021 | Sanofi Aatd Inc. | Abandoned | Abandoned Feb 10, 2021 | not computed | |
| Application 17/315,511 | Serpin Fusion Polypeptides and Methods of Use Thereof Pending Not granted | Sanofi Aatd Inc. | Pending | Not granted | not computed | |
| 1 more patent in this group · Pro | ||||||
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
8 of these are in force and held by Sanofi.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.